Total Funding
2
8
Total FundingVenture - Series Unknown raised
Growth Score 2 in past quarter
-1 pts
Heat Score 8 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
342419
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments.
Patrick Mahaffy: President and Chief Executive OfficerPast Role: Pharmion, President, Chief Executive Officer and Board of Directors- Ann Bozeman: Executive Vice President of Human Resources
About the Company
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients
most likely to benefit from them.
Women Founded
